A new therapy in Epstein-Barr virus-associated lymphoproliferative disease: a case report and a revision of the literature
Abstract Background Systemic chronic active Epstein-Barr virus infection is an extremely rare childhood disease.Since chronic active Epstein-Barr virus infection can trigger the onset of Epstein-Barr virus-associated lymphoproliferative disease.The clinical manifestations of the disease vary according to the site of involvement; therefore, manageme